1Crow TJ, Jones BD, Anable AL, et al. The northwick park study of first episodes of schizophrenia: II. a randomised controlled trial of prophylactic neuroleptic treatment[J]. Br J Psychiatry,1986,148:120.
2Bottlender R, Sato T, J ger M, et al. The impact of the duration of untreated psychosis prior to first psychiatric ad- mission on the 15-year outcome in sehizophrenia[J]. Sehizophr Res,2003,62(1-2) :37.
3Lappin JM, Morgan KD, Morgan C, et al. Duration of untreated psychosis and neuropsychological function in first episode psychosis[J]. Schizophr Res, 2007,95( 1 -3) : 103.
4Addington J, Van Mastrigt S, Addington D. Duration of untreated psychosis., impact on 2-year outcome[J]. Psychol Med,2004,34(2) :277.
5Joyce E, Hutton S, Mutsatsa S, et al. Executive dys function in first-episode schizophrenia and relationship to du ration of untreated psychosis: the West London Study[J]. Br J Psychiatry Suppl,2002,43:38.
6Gottesman II. Schizophrenia epigenesis: past, present, and future[J]. Acta Psychiatr Scand, 1994,384 : 26.
7Phillips L J, YungAR, McGorry PD. Identi cation of young people at risk of psychosis: validation of personal assessment and crisis evaluation clinic intake criteria[J]. Aust New Zealand J Psychiatry,2000,34:164.
8Yung AR, Phillips I.J, Yuen HP, et al. Psychosis prediction: 12-month follow up of a high risk (" prodromal") group[J]. Schizophr Res,2003,60(1) :21.
9Klosterk? tter J, Schultze Lutter F. Is there a primary prevention of schizophrenic psychosis[J]. Fortschr Neurol Psychiatr,2001,69 Suppl(2) : 104.
10Faraone SV, Green AI, Seidman I.J, et al. "Schizotax- ia": clinical implications and new directions for research[J]. Sehizophr Bull,2001,27(1) : 1.
